The Global Ventricular Tachycardia Market is estimated to be valued at USD 15.52 Bn in 2025 and is expected to reach USD 22.28 Bn by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% from ...

Solutions Market growth is driven by rising hospitalization rates, increasing prevalence of chronic diseases, expanding surgical volumes, and growing demand for parenteral nutrition and fluid ...

Baxter International Inc. (NYSE:BAX) is one of the top cheap stocks under $20 to buy now. On December 12, Wells Fargo analyst Larry Biegelsen reiterated a Hold rating on Baxter International Inc.

Baxter (NYSE:BAX) announced new data demonstrating the positive impact of smart infusion pump integration with hospital EMRs. The Deerfield, Illinois-based company announced data in collaboration with ...

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas ...

Data shared in collaboration with The University of Texas Medical Branch, representing an analysis of more than one million intravenous (IV) infusions using Baxter’s Spectrum IQ large volume infusion ...

Pzena Investment Management recently released its third-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. Driven by optimism about AI and a ...

Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on ...

Baxter International Inc. (NYSE: BAX) recalled the Life2000 Ventilation system from the market after identifying a cybersecurity vulnerability that federal regulators say could lead to severe patient ...

Baxter International shares fell sharply this morning as third quarter results missed expectations and the medtech company lowered its 2025 outlook. The Deerfield-based company also announced it would ...